It is with great pride that Pharmaceutical Executive presents the winners of this year’s APEX Awards. Decided by doctors, nurses and other health care professionals across the United States, this year’s ceremony included 30 industry leaders and globally recognized creative agencies.
This year’s winners were announced on November 13, 2024, at the New York Hilton Midtown in New York City.
The winners of the 2024 APEX Awards are as follows:
Aesthetics/Dermatology
Branded (FDA Regulated)
Company:
Sanofi & Regeneron
Agency:
Eversana InTouch
Campaign:
Eczema Skin Gallery
Disease Awareness
Company:
UCB
Agency:
Avant Healthcare
Campaign:
Make History (US HCP Campaign)
Cardiovascular
Branded (FDA Regulated)
Company:
AstraZeneca
Agency:
Addison Whitney
Campaign:
AmyLink / Amyloidosis Evidence Development Programme
Central Nervous System
Branded (FDA Regulated)
Company:
Lundbeck
Agency:
Eversana InTouch
Campaign:
Say "Yep" to Vypeti
Devices
Branded (FDA Regulated)
Company:
NeuroStar
Agency:
EvolveMKD
Campaign:
Breaking Barriers with Neurostar Depression Barometer
Disease Education/Awareness
Company:
Cerapedics Inc
Agency:
Scientific Global
Campaign:
FUSE: Fusion University for Surgical Excellence
Direct-to-Consumer
Branded (FDA Regulated)
Company:
Radius Health
Agency:
AbelsonTaylor
Campaign:
TYMLOS "Add to the Bone" Osteoporosis Consumer Campaign
Direct-to-Patient
Branded (FDA Regulated)
Company:
Arcutis
Agency:
AbelsonTaylor
Campaign:
The Cream That Can
Disease Education/Awareness
Company:
embecta
Agency:
Addison Whitney
Campaign:
From the Beginning | 2023 World Diabetes Day Campaign
Gastroenterology
Branded (FDA Regulated)
Company:
Nestle Health Science
Agency:
AbelsonTaylor
Campaign:
Toilet Monster
Immunology
Disease Education/Awareness
Company:
Pharvaris
Agency:
The Agency Network at MJH LifeSciences
Campaign:
Pharvaris DeflateHAE Awards Video
Men’s Health
Branded (FDA Regulated)
Company:
Sanofi
Agency:
Saatchi & Saatchi Wellness
Campaign:
Your Lucky Day and a Half
Metabolic
Disease Education/Awareness
Company:
Acella Pharmaceuticals
Agency:
Scientific Global
Campaign:
Treating Hypothyroidism
Branded (FDA Regulated)
Company:
Novo Nordisk
Agency:
ConcentricLife
Campaign:
Believe On
Oncology
Disease Education/Awareness
Company:
Elevar Therapeutics
Agency:
The Agency Network at MJH LifeSciences
Campaign:
Elevar uHCC Disease Awareness Campaign
Branded (FDA Regulated)
Company:
Manarini Stemline
Agency:
Biolumina
Campaign:
Picture What's Possible
Ophthalmology
Disease Education/Awareness
Company:
Kala Bio
Agency:
QBFox Healthcomm
Campaign:
Trail
Rare Disease
Branded (FDA Regulated)
Company:
Corcept Therapeutics
Agency:
Eversana InTouch
Campaign:
In the Clutches of Hypercortisolism
Disease Education/Awareness
Company:
Pharvaris
Agency:
The Agency Network at MJH LifeSciences
Campaign:
Pharvaris DeflateHAE Awards Video
Respiratory
Branded (FDA Regulated)
Company:
Boehringer Ingelheim
Agency:
Confideo, LLC
Campaign:
OFEV Holographic Augmented Reality KOL Integrations
Surgery
Branded (FDA Regulated)
Company:
Vericel Corporation
Agency:
AbelsonTaylor
Campaign:
MACI: No Challenge, No Change
Disease Education/Awareness
Company:
Cerapedics Inc
Agency:
Scientific Global
Campaign:
FUSE: Fusion University for Surgical Excellence
Women’s Health
Branded (FDA Regulated)
Company:
Exeltis USA
Agency:
Spark Growth
Campaign:
#LetsLoveEveryBody
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.